ANAPLASTIC THYROID CARCINOMAS
Clinical trials for ANAPLASTIC THYROID CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC THYROID CARCINOMAS trials appear
Sign up with your email to follow new studies for ANAPLASTIC THYROID CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for rare cancers: new immunotherapy combo trial launches
Disease control Recruiting nowThis study tests a combination of two immunotherapy drugs (domvanalimab and zimberelimab) in 154 people with five types of rare advanced cancers that have stopped responding to standard treatments. The goal is to see if this treatment can control the cancer for at least 24 weeks.…
Matched conditions: ANAPLASTIC THYROID CARCINOMAS
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated May 17, 2026 00:39 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new treatment called CD70-targeted CAR-T cells in people with advanced solid tumors, including kidney, lung, and ovarian cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have a specific marke…
Matched conditions: ANAPLASTIC THYROID CARCINOMAS
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 17, 2026 00:29 UTC